MiR-200c was down-regulated in methotrexate-resistant cell line A549.
MiR-200c acted as a tumor suppressor gene in lung cancer cells.
Over expression of miR-200c reduced the resistance of A549 cells to methotrexate through the P53/P21 pathway.
Over expression of miR-200c inhibited cell migration and invasion through the EZH2/E-cad pathway.